Hepatopulmonary syndrome
Hepatopulmonary syndrome (HPS) is a hypoxemia caused by pulmonary vasodilation and abnormal arterial oxygenation due to various acute and chronic liver diseases. In essence, it is a triad of primary liver disease, pulmonary vasodilation, and insufficient arterial oxygenation.
-
Site of disease:
Liver and lungs -
Infectious :
Not contagious -
Frequent population:
Patients with pre-existing liver disease -
Related symptoms:
Shortness of breath Difficulty breathing Liver qi attacking the lungs Supine breathing Liver enlargement -
Concurrent disease:
Related Drugs
Heluo Shugan Capsule
Manufacturer:
Weihai Noda Pharmaceutical Group Co., Ltd.
Torsemide Tablets
Indication: It is used for patients with congestive heart failure, ascites due to liver cirrhosis, and edema caused by kidney disease; it can also be used for patients with essential hypertension.
Silybin Meglumine Tablets
Indication: Used for adjuvant treatment of acute and chronic hepatitis, early cirrhosis, and toxic liver damage.
Manufacturer:
Hunan Qianjin Xieli Pharmaceutical Co., Ltd.
Xin Gan Bao Capsule
Manufacturer:
Hebei Changtian Pharmaceutical Co., Ltd.
Related Ingredients